AG PostFinance insider trades: Cytori Therapeutics (CYTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where AG reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 14, 2018 | CYTX | ↓ Sell | 473,831 | $0.34 | $161K | Direct | Feb 15, 2018 (1d) |
| Feb 13, 2018 | CYTX | ↓ Sell | 286,982 | $0.31 | $90K | Direct | Feb 14, 2018 (1d) |
| Feb 9, 2018 | CYTX | ↓ Sell | 236,155 | $0.34 | $81K | Direct | Feb 12, 2018 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About AG PostFinance's insider trades
AG PostFinance is a 10% owner of Cytori Therapeutics (CYTX). Since Feb 9, 2018, AG has reported no open-market purchases and 3 sales worth $332K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.